Medical Card
Get Your Medical Marijuana Card Today
Meet with a healthcare provider in minutes and receive the best care for the best value.
Explore A-Z conditions
Thyroid Cancer
Cannabis for Thyroid Cancer
Thyroid cancer is a type of cancer that affects the thyroid gland, which is a small, butterfly-shaped gland at the base of the neck that produces hormones. Thyroid cancer is quite rare, and tends to affect women more than men. It has a relatively high survival rate, with 90% of sufferers living at least 5 years after diagnosis.
There is encouraging data confirming cannabinoids’ potential utility when it comes to thyroid cancer, but these are mostly lab and animal studies. It is suggested that cannabinoids like THC and CBD may be useful in inflammation associated with thyroid cancer, as well as regulating dysfunctional hormone production, but clinical trials need to take place to confirm if any of this is true for humans.
Get your medical marijuana card
Connect with a licensed physician online in minutes.
Animal Study
4
Laboratory Study
2
Meta-analysis
6
Total studies
Thyroid Cancer
12
Positive
9 studies
75%
Negative
3 studies
25%
Do I qualify?
Select your state from the drop down and we’ll let you know.
Relevant studies
The information in our comprehensive A to Z encyclopedia comes from real scientific studies.
Uncover the detailed results of these studies and find out how effective medical marijuana is for dozens of conditions.
- A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis.
- Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
- Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.
- Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth
- Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development